The Minnesota Department of Health announced on Wednesday that the agency will add irritable bowel syndrome and obsessive-compulsive disorder to the list of qualifying medical conditions for participation in the state’s medical cannabis program. Under state law, the addition of the new qualifying conditions will become effective beginning on August 1, 2023, according to state officials.

“We are adding the new qualifying conditions to allow patients more therapy options for conditions that can be debilitating,” Minnesota Commissioner of Health Jan Malcolm said in a statement from the health department.

Irritable bowel syndrome (IBS) is a disorder characterized by abdominal pain or discomfort, as well as irregular bowel movements that can result in diarrhea, constipation, both diarrhea and constipation, or bloating. Obsessive-compulsive disorder (OCD) is characterized by recurring, intrusive thoughts that often cause significant emotional distress and anxiety in those living with the disorder. This can lead to repetitive actions or

Read More

Regulators in Arkansas on Monday revoked a medical marijuana cultivator’s license to operate after a judge ruled earlier this month that the state erred when it granted the license two years ago. Doralee Chandler, the director of the Alcoholic Beverage Control Administration and the head regulator of the state Medical Marijuana Commission (MMC), revoked the license from medicinal cannabis cultivator River Valley Relief (RVR) on November 28 at a hearing that lasted nearly an hour.

The Arkansas Medical Marijuana Commission granted RVR a license to cultivate medicinal cannabis in July 2020, making the company the last of eight growers authorized by the state. But another company, 2600 Holdings, filed a lawsuit in January 2021, arguing that RVR should not have been granted the cultivation license. The plaintiff asked the court to disqualify River Valley Relief and award the license to 2600 or provide other relief under the Arkansas Administrative Procedures

Read More